Management of postoperative pain is a major health care challenge that affects 40 – 50 million Americans who undergo a surgical procedure each year. Studies have shown that successful management of postoperative pain can result in shorter recovery times and a faster return to a normal life for patients. Currently, treatment for postoperative pain is dominated by opioid therapeutics, which being prone to addiction and abuse, have precipitated a national health care crisis, with prescription opioids involved in 24% of all opioid-related deaths in 2020.
The goal of Ferdia’s postoperative pain programs is to develop long-acting peptide therapeutics suitable for infusion at the time of surgery and/or once-weekly subcutaneous injection post-surgery as a safe and effective non-addictive alternative for treating postoperative pain.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.